This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Switching antidepressant (tricyclic antidepressants (TCA) to serotonin and noradrenaline reuptake inhibitors (SNRIs) (e.g. duloxetine or venlafaxine)) in adults

Authoring team

Switching antidepressant (tricyclic antidepressants (TCA) to serotonin and noradrenaline reuptake inhibitors (SNRIs))

From all except clomipramine

Cross-taper

  • cross-tapering starting with a low dose SNRI can usually be undertaken cautiously over 2 to 4 weeks, the speed is determined by individual tolerability

From clomipramine

Taper, stop and switch

  • if switching from clomipramine, gradually reduce the dose of clomipramine and stop. Start low dose SNRI the following day

  • cross-tapering is not recommended and should only be undertaken if specialist advice is in place, this is because clomipramine is a potent serotonin reuptake inhibitor so there is a high risk of serotonin syndrome.

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.